Main > A1. CORP. INDEX. O-Om > OcuPhire Pharma Inc./P C2

---

This data is not available for free

OcuPhire Pharma Inc./P C2's subsections
2020. 01.22. In-License Apexian ..
2020. 06.17. Merger Rexahn
2021. 05.18. 2 USA Patents
2022. 06.29. USA Patent
2022. 08.03. USA Patent
2023. 09.27. USA FDA Approval
web-site

OcuPhire Pharma Inc./P C2's products
This section has no products